These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 12609780

  • 1. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ, Aminjavaheri M.
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [Abstract] [Full Text] [Related]

  • 2. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S, Marr JJ.
    N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379
    [Abstract] [Full Text] [Related]

  • 3. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I, Dabiri SH.
    Int J Dermatol; 2007 Aug 12; 46(8):848-52. PubMed ID: 17651170
    [Abstract] [Full Text] [Related]

  • 4. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA, Jaffary F, Ansari N, Siadat AH, Nilforoushan Z, Firouz A.
    J Vector Borne Dis; 2008 Dec 12; 45(4):287-91. PubMed ID: 19248655
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R, Handjani F, Nouhpisheh MK.
    J Dermatolog Treat; 2001 Sep 12; 12(3):159-62. PubMed ID: 12243707
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul 12; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 7. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
    Sadeghian G, Nilforoushzadeh MA.
    Int J Dermatol; 2006 Jul 12; 45(7):819-21. PubMed ID: 16863518
    [Abstract] [Full Text] [Related]

  • 8. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.
    Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ.
    Dermatology; 2004 Jul 12; 209(1):46-9. PubMed ID: 15237267
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
    Munir A, Janjua SA, Hussain I.
    Acta Dermatovenerol Croat; 2008 Jul 12; 16(2):60-4. PubMed ID: 18541100
    [Abstract] [Full Text] [Related]

  • 10. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ.
    Am J Trop Med Hyg; 2007 Oct 12; 77(4):640-6. PubMed ID: 17978064
    [Abstract] [Full Text] [Related]

  • 11. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ, Reiszadae MR, Aminjavaheri M.
    Int J Dermatol; 2002 Jul 12; 41(7):441-3. PubMed ID: 12121563
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P, Yazdanpanah MJ, Vosugh EM, Pezeshkpoor F, Shakeri MT, Moghiman T.
    Am J Trop Med Hyg; 2007 Jul 12; 77(1):99-101. PubMed ID: 17620637
    [Abstract] [Full Text] [Related]

  • 13. Treatment of recurrent cutaneous Leishmaniasis.
    Momeni AZ, Aminjavaheri M.
    Int J Dermatol; 1995 Feb 12; 34(2):129-33. PubMed ID: 7737774
    [Abstract] [Full Text] [Related]

  • 14. Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
    Dastgheib L, Naseri M, Mirashe Z.
    Int J Dermatol; 2012 Dec 12; 51(12):1508-11. PubMed ID: 23171020
    [Abstract] [Full Text] [Related]

  • 15. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG.
    J Infect Dis; 2006 May 15; 193(10):1375-83. PubMed ID: 16619185
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
    Sadeghian G, Nilfroushzadeh MA, Iraji F.
    Clin Exp Dermatol; 2007 Jul 15; 32(4):371-4. PubMed ID: 17376205
    [Abstract] [Full Text] [Related]

  • 17. A comparative study between the efficacy of oral cimetidine and low-dose systemic meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment of cutaneous leishmaniasis.
    Shanehsaz SM, Ishkhanian S.
    Int J Dermatol; 2015 Jul 15; 54(7):834-8. PubMed ID: 26108265
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
    Shamsi Meymandi S, Zandi S, Aghaie H, Heshmatkhah A.
    J Eur Acad Dermatol Venereol; 2011 May 15; 25(5):587-91. PubMed ID: 20666876
    [Abstract] [Full Text] [Related]

  • 19. Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
    Neves DB, Caldas ED, Sampaio RN.
    Trop Med Int Health; 2009 Dec 15; 14(12):1515-22. PubMed ID: 19954451
    [Abstract] [Full Text] [Related]

  • 20. Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia.
    Mlika RB, Hamida MB, Hammami H, Jannet SB, Badri T, Fenniche S, Mokhtar I.
    Dermatol Ther; 2012 Dec 15; 25(6):615-8. PubMed ID: 23210761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.